About Keratin, type II cytoskeletal 4
Keratin, type II cytoskeletal 4 (KRT4) is a protein
from Homo sapiens identified by UniProt accession
P19013, 520 residues long.
MolForge cross-references it against 0 known binders and
176 disease associations.
Target properties
| Protein name | Keratin, type II cytoskeletal 4 |
| UniProt accession | P19013 |
| Gene | KRT4 |
| Organism | Homo sapiens |
| Length | 520 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (176)
Diseases linked to this target (Open Targets).
- White sponge nevus · score 0.64
- white sponge nevus 1 · score 0.62
- head and neck squamous cell carcinoma · score 0.19
- genetic disorder · score 0.19
- prostate adenocarcinoma · score 0.19
- glioblastoma multiforme · score 0.19
- clear cell renal carcinoma · score 0.18
- ovarian cancer · score 0.18
- breast adenocarcinoma · score 0.18
- esophageal cancer · score 0.14
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P19013-F1 | alphafold | PREDICTED | 69.13 | — |
Amino-acid sequence (520 residues)
MIARQQCVRG GPRGFSCGSA IVGGGKRGAF SSVSMSGGAG RCSSGGFGSR SLYNLRGNKS ISMSVAGSRQ GACFGGAGGF GTGGFGGGFG GSFSGKGGPG FPVCPAGGIQ EVTINQSLLT PLHVEIDPEI QKVRTEEREQ IKLLNNKFAS FIDKVQFLEQ QNKVLETKWN LLQQQTTTTS SKNLEPLFET YLSVLRKQLD TLGNDKGRLQ SELKTMQDSV EDFKTKYEEE INKRTAAEND FVVLKKDVDA AYLNKVELEA KVDSLNDEIN FLKVLYDAEL SQMQTHVSDT SVVLSMDNNR NLDLDSIIAE VRAQYEEIAQ RSKAEAEALY QTKVQQLQIS VDQHGDNLKN TKSEIAELNR MIQRLRAEIE NIKKQCQTLQ VSVADAEQRG ENALKDAHSK RVELEAALQQ AKEELARMLR EYQELMSVKL ALDIEIATYR KLLEGEEYRM SGECQSAVSI SVVSGSTSTG GISGGLGSGS GFGLSSGFGS GSGSGFGFGG SVSGSSSSKI ISTTTLNKRR
Explore Keratin, type II cytoskeletal 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets